Malignant neoplasm of rectum

C3_RECTUM

rectum cancer: A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C20 Cause of death: ICD-9 — 154 Cause of death: ICD-8 — 1541 Cause of death: excluded ICD-9 — 1540\|154[2-3] Cancer registry: Topography ICD-O-3 — C20 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3975
4. Check minimum number of events None	3975
5. Include endpoints None	3975
6. Filter based on genotype QC (FinnGen only)	3859

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_RECTUM
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C20
COD_ICD_9	154
COD_ICD_8	1541
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1540\|154[2-3]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C20
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of rectum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Squamous cell neoplasms and carcinoma of rectum

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3859	1457	2402
Unadjusted period prevalence (%)	0.88	0.52	1.10
Median age at first event (years)	67.83	66.30	68.75

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3975: Matched controls
39738

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.2

317.4

327

290

WF049

NOMESCO Finland

Radiotherapy of metastasis

1099.1

315.8

305

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3097.7

312.4

298

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

10.0

307.7

438

484

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

370.7

307.7

430

JG1BG

NOMESCO Finland

MRI of rectum

623.5

307.7

630

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

6803.9

307.7

593

JN4BD

NOMESCO Finland

Extensive body CT

20.8

307.7

1311

919

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1512.5

307.7

407

WZC30

NOMESCO Finland

Teaching

5.8

307.7

1130

2564

WF002

NOMESCO Finland

Radical radiotherapy

156.8

307.7

383

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3435

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

6695.0

307.7

585

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

19.8

307.7

1111

764

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

94.9

307.7

542

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

25.9

307.7

1945

1420

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

161.0

307.7

339

UJF32

NOMESCO Finland

Coloscopy

10.6

307.7

2718

6743

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

513

WX402

NOMESCO Finland

General anaesthesia

4.4

307.7

1198

3528

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

110.4

307.7

268

UJG02

NOMESCO Finland

Proctoscopy

20.6

307.7

519

287

WX408

NOMESCO Finland

General anesthesy, balanced

4.4

307.7

1630

5376

A03FA01

ATC

metoclopramide; systemic, rectal

18.0

307.7

2073

2267

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

311

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

213.8

307.7

203

JG1CG

NOMESCO Finland

Extensive MRI of rectum

510.4

307.7

531

JFF23

NOMESCO Finland

Transversostomy

276.5

307.7

883

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

3731.2

307.7

352

N02AA05

ATC

oxycodone; systemic

4.5

307.7

1183

3404

D75

ICPC

Malignant neoplasm colon/rectum

648.1

307.7

511

XX3DW

NOMESCO Finland

Time consuming IT work

14.9

307.7

951

821

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

356.4

307.7

499

JN4AD

NOMESCO Finland

Body CT examination

12.2

307.7

1009

1077

C61

ICD-10 Finland

Malignant neoplasm of prostate

557.2

307.7

357

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

22.4

307.7

642

339

JFF10

NOMESCO Finland

Loop enterostomy

98.3

307.7

214

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

103.4

307.7

178

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

7.8

307.7

505

730

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

526.3

307.7

465

C20

ICD-10 Finland

Malignant neoplasm of rectum

8903.0

307.7

1260

JN4CD

NOMESCO Finland

Very extensive body CT

18.7

307.7

385

226

B01AB05

ATC

enoxaparin; parenteral

5.7

307.7

2274

7591

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

16384.0

307.7

1986

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

30.7

307.7

712

280

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

703

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2480.6

307.7

463

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

131.9

307.7

282

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

2189

Z51.5

ICD-10 Finland

Palliative care

11.5

307.7

688

709

TJF80

NOMESCO Finland

Ostomy education

192.2

307.7

576

WZC00

NOMESCO Finland

Treatment plan or consultation

4.7

307.7

1947

6687

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

447

ZXC96

NOMESCO Finland

Robot assisted procedure

41.3

307.7

259

Z93.3

ICD-10 Finland

Colostomy status

151.6

307.7

538

L01BC06

ATC

capecitabine; oral

+∞

307.7

1803

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

307.7

963

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1723.0

307.7

708

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

3423

TPH07

NOMESCO Finland

Cathetrisation of artery

5.1

307.7

946

2296

A04AA01

ATC

ondansetron; systemic, rectal

17.6

307.7

549

358

SPAT1125

SPAT

Stoma care and guidance

16.0

307.7

310

209

WX600

NOMESCO Finland

Single shot through catheter

75.0

307.7

368

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

260.4

307.7

793

WX302

NOMESCO Finland

Thoracal epidural anesthesy

57.6

307.7

1314

338

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

525

A04AA02

ATC

granisetron; systemic, transdermal

1236.8

307.7

1014

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

500

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

530.2

307.7

468

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

7286.6

307.7

628

H02AB02

ATC

dexamethasone; systemic

95.7

307.7

1206

180

B01AB10

ATC

tinzaparin; parenteral

5.5

306.9

662

1381

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

38.4

292.0

180

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

290.2

275

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

13.0

282.3

278

229

ZX070

NOMESCO Finland

Intensity modified radiotherapy

959.7

277.4

269

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

267.8

254

ZX090

NOMESCO Finland

Other technic of radiotherapy

317.3

263.5

265

ZXE20

NOMESCO Finland

More than three and less than five hours

3.9

261.7

931

2862

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

2437.8

250.5

240

L03AA02

ATC

filgrastim; parenteral

70.4

250.3

136

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

1275.3

248.4

240

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

129.0

247.4

125

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.6

245.9

506

1004

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

841.8

244.4

238

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

233.6

222

L02AE02

ATC

leuprorelin; implant, parenteral

52.5

230.5

132

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

14.6

226.3

206

148

WF004

NOMESCO Finland

Palliative radiotherapy

2170.7

225.0

216

A04AA55

ATC

palonosetron, combinations; systemic

+∞

222.0

211

JN3AD

NOMESCO Finland

Abdominal CT examination

4.0

219.7

731

2125

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

322.2

210.7

212

ZX120

NOMESCO Finland

Intravenous

4.5

205.3

562

1410

WF003

NOMESCO Finland

Adjuvant radiotherapy

526.6

203.6

201

116

Kela drug reimbursment

Prostate cancer

+∞

202.8

193

WW500

NOMESCO Finland

Blood transfusion

8.7

202.7

265

324

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.0

201.6

236

250

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

41.6

200.6

121

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

18.7

191.6

153

L01BC59

ATC

trifluridine, combinations; systemic

+∞

190.1

181

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

188.0

179

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

640.8

187.4

184

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

50.4

187.1

108

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

185.7

448

1013

JF2AB

NOMESCO Finland

Colongraphy with X-ray

62.2

185.7

103

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.9

185.4

621

1802

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

93.1

173.9

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.8

172.0

329

605

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.0

170.3

269

408

D18

ICPC

Change in faeces/bowel movements

7.5

168.5

248

348

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.2

166.1

363

753

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.2

165.8

490

1295

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

47.3

165.7

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

164.7

157

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

163.7

156

D99

ICPC

Disease digestive system other

13.3

160.2

153

119

JAH00

NOMESCO Finland

Laparotomy

7.1

158.8

245

362

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

9.9

158.6

186

197

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

156.3

149

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.5

155.0

621

2017

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

154.1

147

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

29.9

154.0

102

JFB00

NOMESCO Finland

Partial resection of small intestine

10.6

153.0

170

167

TQW40

NOMESCO Finland

Remowal of suture of skin

4.1

152.2

452

1196

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

23.8

151.8

109

A04AD12

ATC

aprepitant; systemic

1532.1

149.9

145

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

20.5

144.2

110

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

143.6

137

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

141.5

135

Z93

ICD-10 Finland

Artificial opening status

189.3

140.6

146

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

1418.8

140.4

136

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

140.4

134

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.8

139.3

329

727

R4110

NOMESCO Finland

Physiotherapy

2.4

136.7

1308

6692

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

40.3

136.6

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

14.1

135.9

125

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.8

135.2

258

472

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

49.7

134.6

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

18.7

133.4

106

SPAT1262

SPAT

Handing over of treatment supplies

2.6

133.1

1041

4846

Z51.0

ICD-10 Finland

Radiotherapy session

1310.3

131.0

127

369

Kela drug reimbursment

Regorafenib

+∞

130.9

125

ZZR00

NOMESCO Finland

Flap of skin

15.1

130.0

115

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

129.8

1071

5105

Z43.3

ICD-10 Finland

Attention to colostomy

174.6

129.2

135

115

Kela drug reimbursment

Breast cancer

+∞

128.8

123

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

648.5

128.2

126

JGB36

NOMESCO Finland

Wide excision of rectum

1278.3

127.8

124

L03AA13

ATC

pegfilgrastim; parenteral

434.5

127.6

127

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

1267.6

126.8

123

A79

ICPC

Malignancy NOS

170.6

126.2

132

PJA12

NOMESCO Finland

Sentinel node biopsy

423.8

124.5

124

L02BG04

ATC

letrozole; oral

31.4

122.7

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

26.0

121.0

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

119.4

114

K56.7

ICD-10 Finland

Ileus, unspecified

7.3

117.5

175

248

176

Kela drug reimbursment

Regorafenib

+∞

116.2

111

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

115.1

110

A06AH03

ATC

naloxegol; oral

16.4

109.8

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

49.2

108.4

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

107.8

103

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

107.8

103

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

107.8

103

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.9

106.1

329

892

R4190

NOMESCO Finland

Nutritional therapy

6.3

104.7

181

300

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.4

104.1

271

645

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

7.3

102.2

153

218

Z93.2

ICD-10 Finland

Ileostomy status

21.5

101.7

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

9.1

99.6

123

139

B01AB04

ATC

dalteparin; parenteral

3.9

98.1

304

823

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.2

96.8

170

286

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.7

96.6

186

342

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

14.9

96.5

JFF26

NOMESCO Finland

Sigmoidostomy

43.7

93.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

929.6

93.2

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

89.9

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

89.9

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

20.0

89.7

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

22.8

89.1

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.6

88.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.2

88.9

188

376

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

20.3

88.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

88.8

585

2464

D70.82

ICD-10 Finland

Drug-induced neutropenia

17.9

88.8

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

447.4

88.5

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

305.6

88.1

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

88.1

1484

9162

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

87.8

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

87.8

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

301.9

87.1

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

84.7

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

15.9

83.8

1XC07, ,

NOMESCO Finland

+∞

83.6

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.1

83.4

238

606

Z43.2

ICD-10 Finland

Attention to ileostomy

144.7

80.3

HAB40

NOMESCO Finland

Wedge excision of mammary gland

15.2

78.5

N03AX16

ATC

[U] pregabalin

2.1

78.4

1024

5732

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

773.0

77.6

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

77.3

JAH01

NOMESCO Finland

Laparoscopy

4.6

76.1

187

424

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.8

74.6

138

244

Y77

ICPC

Malignant neoplasm prostate

196.2

74.4

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

74.2

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

374.1

73.9

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

35.8

73.2

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

20.3

73.1

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

22.4

72.1

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.9

71.6

220

590

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

71.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

5.3

70.5

144

279

N02BE01

ATC

paracetamol; systemic, rectal

2.4

70.4

3493

29910

XX1AD

NOMESCO Finland

Other CT-examination

150.7

70.2

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

13.4

69.9

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.2

69.9

104

147

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

16.2

69.3

L02BB03

ATC

bicalutamide; oral

+∞

68.9

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

36.2

68.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.4

68.2

177

419

Z31.5

ICD-10 Finland

Genetic counselling

4.7

68.0

163

362

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

18.2

67.2

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

669.2

67.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.0

66.9

198

517

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

14.5

66.5

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

230.5

66.4

D16

ICPC

Rectal bleeding

4.7

65.9

155

339

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.9

65.3

102

152

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.5

64.9

235

704

JFF24

NOMESCO Finland

Laparoscopic transversostomy

327.2

64.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

63.5

682

3516

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

27.1

62.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.9

62.7

146

TPX15

NOMESCO Finland

Removal of vascular injection port

24.7

62.1

WX704

NOMESCO Finland

Intubation

2.7

61.9

353

1373

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

61.6

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

12.4

61.6

JFB30

NOMESCO Finland

Right hemicolectomy

10.2

60.2

E0000UV, ,

ATC

1.8

60.1

1555

10659

Z3231

NOMESCO Finland

Registered nurse

1.9

60.0

1092

6744

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

596.8

59.9

K92.1

ICD-10 Finland

Melaena

2.8

58.8

319

1208

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

58.5

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

23.6

58.3

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

12.6

58.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

565.9

56.7

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

56.4

L01XE21

ATC

[U] regorafenib

+∞

55.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

55.2

1091

6881

G04BE03

ATC

sildenafil; oral

10.0

55.1

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.1

54.9

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

545.3

54.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

280.0

54.3

L01BC53

ATC

tegafur, combinations; systemic

+∞

54.3

D17

ICPC

Incontinence of bowel

6.8

54.3

127

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.8

54.3

127

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

144.5

54.0

D28

ICPC

Limited function/disability (D)

16.8

53.9

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

185.8

53.0

HAC20

NOMESCO Finland

Total mastectomy

115.6

52.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.3

52.6

144

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

52.2

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

52.2

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

52.1

300

1170

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

20.2

52.1

ZZR10

NOMESCO Finland

Flap of skin and muscle

18.8

51.8

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.2

50.4

106

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

258.6

50.2

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.4

50.1

127

295

UJF30

NOMESCO Finland

Ileoscopy through colon

2.2

49.9

442

2099

JHA00

NOMESCO Finland

Anal or perianal incision

6.0

49.3

147

R50.9

ICD-10 Finland

Fever, unspecified

2.1

49.2

562

2945

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

131.7

48.9

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.2

47.8

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.9

47.7

107

225

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

47.0

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

47.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

47.0

L01EX05

ATC

regorafenib; oral

+∞

47.0

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

47.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

47.0

1425

10024

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

165.3

46.9

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

4.4

46.3

117

271

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

45.9

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

452.7

45.3

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

15.7

45.2

6435

FHL

Abdominoperineal resection and colostomy

158.5

44.9

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

44.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

44.7

149

422

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

44.5

361

1650

V03AF03

ATC

calcium folinate; systemic

442.5

44.3

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

97.2

43.8

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

11.7

43.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

43.5

1815

13724

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

42.8

767

4648

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

42.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

42.2

265

1077

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

41.7

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

41.7

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.4

41.5

151

453

D29

ICPC

Digestive symptom/complaint other

4.0

41.5

120

308

J01MA12

ATC

levofloxacin; systemic

1.8

41.4

743

4500

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.3

41.3

108

257

L02BA01

ATC

tamoxifen; oral

60.7

41.3

JEA00

NOMESCO Finland

Appendectomy

2.7

41.2

227

864

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.4

41.1

148

441

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

40.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

40.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

40.6

329

1501

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.8

40.2

189

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

16.3

40.1

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

207.0

39.9

D77

ICPC

Malignant digestive neopl other/NOS

141.4

39.8

OAB50, ,

SPAT

2.4

39.7

276

1176

UJF34

NOMESCO Finland

Left colonoscopy

8.1

39.7

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

39.6

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

52.8

39.5

HA1AA

NOMESCO Finland

X-ray mammography

3.7

39.4

126

347

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.0

39.2

170

C50.99

ICD-10 Finland

Breast, unspecified

391.2

39.1

S18

ICPC

Laceration/cut

1.6

38.8

1704

12924

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

+∞

38.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

38.6

WGA11

NOMESCO Finland

Planning of pain management

11.9

38.5

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.4

38.4

A02BC02

ATC

pantoprazole; systemic

1.6

37.8

2531

21020

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

37.7

217

845

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

37.5

JFB20

NOMESCO Finland

Ileocaecal resection

10.6

37.5

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

370.7

37.1

L03AA14

ATC

lipegfilgrastim; parenteral

370.7

37.1

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

9.1

36.8

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

191.7

36.8

JJB30

NOMESCO Finland

Excision of two segments of liver

191.7

36.8

K61.1

ICD-10 Finland

Rectal abscess

12.0

36.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

36.5

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.9

36.3

166

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

80.9

35.8

P01AB01

ATC

metronidazole; oral, rectal

1.6

35.8

1348

9831

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.2

35.7

238

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

35.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

35.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

53.0

35.4

ZXE00

NOMESCO Finland

One hour or less

1.6

35.1

1332

9720

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

350.2

35.0

ZXD05

NOMESCO Finland

Urgent procedure

1.6

34.7

1127

7933

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

34.4

C209, ,

ICD-10 Finland

+∞

34.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

34.1

2373

19648

6434

FHL

Anterior resection

65.5

34.0

KA3EB

NOMESCO Finland

Antegrade pyelography

11.0

33.8

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.4

33.7

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

33.5

216

889

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.6

33.3

111

315

JFA70

NOMESCO Finland

Suture of small intestine

12.9

33.1

ZX112

NOMESCO Finland

Subcutaneous

6.1

33.1

Z71.8

ICD-10 Finland

Other specified counselling

1.6

33.0

1006

6963

A06AD11

ATC

lactulose; oral

1.7

32.8

648

4011

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.3

32.6

UKC02

NOMESCO Finland

Cystoscopy

1.7

32.5

663

4139

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

32.3

293

1397

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

32.3

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

32.3

J01MA02

ATC

ciprofloxacin; systemic

1.5

32.1

1481

11218

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

319.5

31.9

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

319.5

31.9

ZX121

NOMESCO Finland

Central venous catheter

34.5

31.8

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

31.8

110

320

LEC00

NOMESCO Finland

Partial excision of vagina

88.3

31.7

JKA20

NOMESCO Finland

Cholecystectomy

3.0

31.7

141

478

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.4

31.6

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

31.3

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

31.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

31.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.1

31.2

213

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.9

30.5

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

30.2

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

30.2

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

30.2

250

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

30.1

299

1477

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

29.5

160

604

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

29.2

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

29.2

JN2AD

NOMESCO Finland

CT examination of lower part of abdomen

11.6

29.1

WX882

NOMESCO Finland

High dependency care

3.0

29.0

128

432

JAD10

NOMESCO Finland

Repair of incisional hernia

5.8

28.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

28.9

559

3432

LCD00

NOMESCO Finland

Hysterectomy

2.9

28.7

141

505

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.0

28.4

124

UJH02

NOMESCO Finland

Anoscopy

2.5

28.2

175

707

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

28.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

28.1

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

28.1

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

28.1

N02AX02

ATC

tramadol; systemic, rectal

1.5

28.0

1566

12231

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

10.4

28.0

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.4

27.8

196

840

C50

ICD-10 Finland

Malignant neoplasm of breast

283.4

27.8

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

283.4

27.8

SPAT1153

SPAT

Removal of sutures

1.5

27.7

1145

8420

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

100.8

27.7

TJG20

NOMESCO Finland

Transanal irrigation

28.7

27.6

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.6

27.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

27.4

440

2556

KC1GB

NOMESCO Finland

Cystography with X-ray

30.2

27.2

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

27.1

ZX050

NOMESCO Finland

Stereotactic radiotherapy

38.1

27.1

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

140.9

26.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

26.1

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

26.1

XX2RW, ,

NOMESCO Finland

7.2

25.8

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

8.5

25.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

262.2

25.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

135.9

25.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

25.5

284

1463

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.0

25.4

187

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.0

25.1

L02BX02

ATC

degarelix; parenteral

+∞

25.0

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

25.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

25.0

536

3374

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

30.2

25.0

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

39.1

24.9

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.3

24.8

147

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

24.6

1145

8581

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.8

24.5

116

R19.4

ICD-10 Finland

Change in bowel habit

2.8

24.4

123

447

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

24.3

592

3850

JAG00

NOMESCO Finland

Repair of other hernia

29.3

24.0

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

56.4

24.0

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

56.4

24.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

24.0

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

24.0

WX610

NOMESCO Finland

Patient controlled analgesia

7.7

23.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.2

23.7

148

NET99

NOMESCO Finland

Other operation on pelvis

241.3

23.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

23.6

198

914

R33

ICD-10 Finland

Retention of urine

1.8

23.4

380

2212

WX892

NOMESCO Finland

Monitored bed care

1.9

23.3

305

1659

JN6AD

NOMESCO Finland

CT of torso and neck

6.1

23.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

23.0

278

1472

KBV00

NOMESCO Finland

Insertion of stent into ureter

6.5

23.0

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

22.9

1XC08, ,

NOMESCO Finland

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

22.9

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

22.9

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

22.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

22.8

285

1526

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

65.3

22.8

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

30.2

22.8

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

83.9

22.7

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

9.4

22.6

K56.0

ICD-10 Finland

Paralytic ileus

4.0

22.6

158

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

23.0

22.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

22.5

277

K62.1

ICD-10 Finland

Rectal polyp

4.0

22.2

160

XKD00

NOMESCO Finland

Uroflowmetry

1.6

22.2

629

4235

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.2

21.9

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

21.9

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

21.9

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

21.9

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

21.9

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

21.9

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

21.9

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

21.9

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

29.2

21.8

G04CA02

ATC

tamsulosin; oral

1.4

21.8

1170

8967

JFF30

NOMESCO Finland

Other colostomy

25.2

21.7

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

221.1

21.6

UJF32, ,

SPAT

2.7

21.6

115

431

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

115.6

21.6

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

4.2

21.4

138

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

21.2

207

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

60.3

20.9

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

60.3

20.9

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.8

20.9

172

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

20.8

ZXC40

NOMESCO Finland

Use of ultrasound

7.7

20.8

JFB43

NOMESCO Finland

Left hemicolectomy

7.7

20.8

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.4

20.8

116

L02AE04

ATC

triptorelin; parenteral

211.0

20.6

128

Kela drug reimbursment

Cancers of female genital organs

211.0

20.6

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.8

20.5

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

15.8

20.5

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.0

19.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

19.8

202

K62.7

ICD-10 Finland

Radiation proctitis

+∞

19.8

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

19.8

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

19.8

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

19.8

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

19.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

19.8

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

19.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

19.5

648

9012

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

19.5

668

9229

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

19.4

387

2383

C209, 8148, 2

ICD-O-3

46.2

19.2

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

7.2

19.1

GDC00

NOMESCO Finland

Lobectomy of lung

22.6

19.0

KBH20

NOMESCO Finland

Replantation of ureter

20.1

19.0

WX002

NOMESCO Finland

Sedation and analgesia

1.5

19.0

684

4836

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

55.3

18.9

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.8

18.9

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

18.9

188

929

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

18.9

147

659

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

18.8

528

3538

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

18.8

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

18.8

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

18.8

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

18.8

X76

ICPC

Malignant neoplasm breast female

70.2

18.7

GDB10

NOMESCO Finland

Wedge resection of lung

27.9

18.7

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

18.8

18.6

S77

ICPC

Malignant neoplasm of skin

20.9

18.6

G04BE01

ATC

alprostadil; parenteral, urethral

3.1

18.6

262

M25.5

ICD-10 Finland

Pain in joint

0.7

18.4

542

7742

JFA42

NOMESCO Finland

Endoscopic injection in colon

6.4

18.4

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

44.2

18.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

18.2

592

8287

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

18.1

136

601

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.3

17.8

A28

ICPC

Limited function/disability NOS

1.5

17.8

700

5034

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

17.7

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

17.7

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

17.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

17.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

17.7

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.6

17.7

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

5.2

17.7

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

36.9

17.6

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

180.7

17.5

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

180.7

17.5

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

180.7

17.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

17.4

141

642

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

28.9

17.4

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

42.2

17.3

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.2

17.2

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.5

17.0

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

50.2

17.0

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

16.8

508

7231

8010/3-C20.9

ICD-O-3

Carcinoma, NOS, of rectum, NOS

+∞

16.7

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

16.7

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

16.7

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

16.7

R15

ICD-10 Finland

Faecal incontinence

2.4

16.7

112

471

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

90.4

16.6

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

16.4

221

1212

R03AC02

ATC

salbutamol; inhalant

0.7

16.2

1258

15262

Z3226

NOMESCO Finland

Physiotherapist

1.5

16.1

594

4209

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

4.8

16.1

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

16.1

347

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.9

16.0

123

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.0

15.9

110

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

14.5

15.8

R18

ICD-10 Finland

Ascites

3.1

15.8

217

R19.5

ICD-10 Finland

Other faecal abnormalities

3.0

15.7

228

K83.1

ICD-10 Finland

Obstruction of bile duct

4.2

15.7

C10AX09

ATC

ezetimibe; oral

0.6

15.7

306

4814

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

15.7

269

1588

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

15.7

JAL30

NOMESCO Finland

Omentectomy

7.2

15.7

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

15.6

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

15.6

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

15.6

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

15.6

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

15.6

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

15.6

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

15.6

KA1FN

NOMESCO Finland

Isotope renography

6.0

15.6

JFC20

NOMESCO Finland

Other enterocolostomy

85.4

15.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

15.4

391

2554

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.7

15.4

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

15.3

237

1358

N32.1

ICD-10 Finland

Vesicointestinal fistula

6.7

15.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

28.7

15.2

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

15.2

135

640

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

17.8

15.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.8

15.0

267

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

11.8

15.0

A07DA03

ATC

loperamide; oral

2.2

15.0

132

623

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

14.0

15.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

15.0

506

7071

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

14.9

144

704

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

5.8

14.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

31.8

14.8

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.3

14.7

164

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

14.7

536

7385

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

14.6

158

805

M01AC06

ATC

meloxicam; systemic, rectal

0.7

14.6

795

10226

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

14.6

JFC10

NOMESCO Finland

Ileotransversostomy

+∞

14.6

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

14.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

14.6

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

14.6

L02BB04

ATC

enzalutamide; oral

+∞

14.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

14.6

L01AX03

ATC

temozolomide; systemic

+∞

14.6

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

14.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

C10AA07

ATC

rosuvastatin; oral

0.7

14.5

769

9938

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.6

14.4

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.8

14.4

203

1130

JFF13

NOMESCO Finland

Terminal enterostomy

15.4

14.4

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

15.4

14.4

WVA20

NOMESCO Finland

Medicine administration

2.5

14.3

344

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.0

14.3

157

806

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

11.4

14.2

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

14.2

189

1034

JFB50

NOMESCO Finland

Other resection of colon

13.4

14.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.7

14.1

120

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.3

14.1

159

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

14.0

132

641

SPAT1131

SPAT

Colonoscopy

2.1

13.9

124

588

H01CB02

ATC

octreotide; parenteral

30.1

13.9

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

30.1

13.9

K61.0

ICD-10 Finland

Anal abscess

3.1

13.8

181

L02BG03

ATC

anastrozole; oral

53.5

13.8

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

20.1

13.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

13.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

13.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.5

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

13.5

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

13.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

13.5

G47.3

ICD-10 Finland

Sleep apnoea

0.7

13.5

438

6180

Z93.8

ICD-10 Finland

Other artificial opening status

140.4

13.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

140.4

13.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

140.4

13.4

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

25.8

13.3

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

25.8

13.3

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

18.3

13.3

N02AA01

ATC

morphine; systemic, rectal

3.0

13.2

186

Z2221

NOMESCO Finland

Medical doctor

1.4

13.2

821

6363

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

13.8

13.2

C10AA05

ATC

atorvastatin; oral

0.8

13.2

1233

14717

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.3

13.1

146

K60.4

ICD-10 Finland

Rectal fistula

12.2

13.1

L08

ICPC

Shoulder symptom/complaint

0.7

12.9

399

5693

WX250

NOMESCO Finland

Intercostal blockade

19.1

12.9

WPB10

NOMESCO Finland

Making a convalescent care decision

14.1

12.7

R52.0

ICD-10 Finland

Acute pain

2.3

12.6

396

JHA10

NOMESCO Finland

Biopsy of anal canal

12.3

12.6

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.0

12.5

176

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

12.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

12.5

JF2CG

NOMESCO Finland

Extensive MRI of colon

+∞

12.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

12.5

L01BC04

ATC

carmofur; oral

+∞

12.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

12.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

12.5

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

12.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

12.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

12.5

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

24.4

12.4

OAA41

NOMESCO Finland

Health check based on individual needs

130.4

12.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

130.4

12.4

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

130.4

12.4

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

130.4

12.4

TKC22

NOMESCO Finland

Catheterisation instruction

2.3

12.4

387

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.5

12.4

117

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.5

12.3

122

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

14.3

12.2

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

12.2

124

619

J01DB01

ATC

cefalexin; oral

1.3

12.2

2843

26172

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.8

12.2

D07AA02

ATC

hydrocortisone; topical

1.5

12.1

400

2765

WZC15, ,

NOMESCO Finland

18.1

12.0

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.4

12.0

129

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

12.0

131

671

L02AE03

ATC

goserelin; implant

8.7

12.0

ZZR30

NOMESCO Finland

Flap of muscle

5.7

11.9

JFB40

NOMESCO Finland

Resection of transverse colon

46.8

11.9

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

46.8

11.9

KDE20

NOMESCO Finland

Removal of foreign body from urethra

4.7

11.9

K65.0

ICD-10 Finland

Acute peritonitis

3.1

11.8

161

KBV10

NOMESCO Finland

Removal of stent from ureter

4.2

11.8

B01AC04

ATC

clopidogrel; oral

0.7

11.7

422

5859

L03

ICPC

Low back symptom/complaint

0.7

11.7

491

6635

C01DA14

ATC

isosorbide mononitrate; oral

0.7

11.7

430

5948

R03DC03

ATC

montelukast; oral

0.6

11.7

215

3442

Z93.4

ICD-10 Finland

Other artificial openings of gastrointestinal tract status

30.1

11.6

GDB20

NOMESCO Finland

Segmental resection of lung

65.1

11.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

19.0

11.6

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

22.9

11.6

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

22.9

11.6

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

11.5

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

8490/3-C20.9

ICD-O-3

Signet ring cell carcinoma of rectum, NOS

+∞

11.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

NET64

NOMESCO Finland

Repair of pelvic floor with flap

+∞

11.5

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

11.5

L02BX03

ATC

abiraterone; oral

+∞

11.5

R01AD09

ATC

mometasone; nasal

0.8

11.4

902

11072

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

11.4

242

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

120.3

11.4

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.8

11.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

11.2

304

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

11.2

660

8446

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.7

11.1

211

JJA20

NOMESCO Finland

Open biopsy of liver

11.2

11.0

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

999

2502

5.00

307.65

2.0

2.2

31.39

37.33

u/l

1.55

921

2095

(40768804) Tissue Pathology biopsy report

2038

9130

3.53

307.65

2.8

1.6

—

(3022145) Colonoscopy Study observation

1764

2971

9.87

307.65

1.6

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1187

3018

5.18

307.65

2.6

2.2

7.42

8.00

umol/l

0.38

1103

2589

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1762

6587

4.01

307.65

3.3

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1169

2262

6.90

307.65

2.3

2.0

0.21

0.20

g/l

4.96

1137

2038

(4035726) Immunohistochemistry procedure

908

778

14.83

307.65

1.4

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

2104

8598

4.07

307.65

3.5

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2741

12986

4.58

307.65

3.8

2.4

—

(3002256) Pathology report gross observation

883

2145

5.00

307.65

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3041

1585

78.37

307.65

9.6

1.4

42.28

2.73

ug/l

3.46

2782

1183

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

890

570

19.82

307.65

5.9

1.8

607.03

23.89

u/ml

0.78

817

447

(3024561) Albumin [Mass/volume] in Serum or Plasma

2718

12921

4.49

307.65

10.7

3.9

33.23

35.37

g/l

65.87

2648

11770

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

445

335

14.83

307.65

5.0

1.8

58.38

22.10

u/ml

3.52

403

301

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2941

14845

4.77

307.65

14.7

3.7

10.99

12.26

umol/l

5.70

2887

13879

(3022217) INR in Platelet poor plasma by Coagulation assay

2762

15777

3.46

286.34

12.2

19.2

1.21

1.38

inr

20.75

756

4364

(3033658) Prothrombin time (PT) actual/Normal

1659

7147

3.27

276.48

5.0

3.6

89.63

84.90

12.31

1650

6953

(3013650) Neutrophils [#/volume] in Blood by Automated count

2631

16142

2.86

210.71

16.9

6.2

3.90

4.38

e9/l

22.24

2347

13812

(3023368) Bacteria identified in Blood by Culture

1734

8673

2.77

206.85

5.1

3.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1855

9664

2.72

203.25

2.5

2.3

57.53

60.56

u/l

1.36

1788

8839

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3248

23220

3.18

179.34

16.1

5.4

88.96

75.90

u/l

26.50

3171

21435

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1698

9065

2.52

168.82

4.3

2.6

30.77

35.57

u/l

1.55

1657

8498

(3003694) ABO and Rh group [Type] in Blood

1424

7034

2.60

166.44

1.4

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

553

1651

3.73

157.11

8.7

10.0

—

(3037121) Protein [Mass/volume] in Urine

411

1016

4.40

151.49

6.3

2.6

0.19

0.34

g/l

4.76

315

360

(3015377) Calcium [Moles/volume] in Serum or Plasma

1697

9628

2.33

140.64

8.1

2.1

2.34

2.35

mmol/l

1.19

1573

8026

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1141

5578

2.47

131.01

9.3

2.2

2.48

2.45

mmol/l

18.16

1069

4745

(3002173) Hemoglobin [Mass/volume] in Arterial blood

761

3089

2.81

127.50

8.0

7.8

117.20

122.48

g/l

12.01

741

3002

(3012095) Magnesium [Moles/volume] in Serum or Plasma

980

4560

2.52

124.36

5.6

2.5

0.78

0.82

mmol/l

20.29

945

4180

(3016502) Oxygen saturation in Arterial blood

801

3431

2.67

120.21

7.7

7.3

97.25

94.98

29.59

772

3292

(3002582) Erythrocytes [#/volume] in Urine

1594

9289

2.19

118.66

3.5

3.1

99.96

68.57

e6/l

0.41

1258

7089

(3013826) Glucose [Moles/volume] in Serum or Plasma

2630

18647

2.21

117.55

6.0

4.5

6.99

6.89

mmol/l

1.56

2549

17428

(3014111) Lactate [Moles/volume] in Serum or Plasma

691

2799

2.78

115.35

6.3

6.6

1.21

1.42

mmol/l

5.67

675

2718

(3003396) Base excess in Arterial blood by calculation

840

3783

2.55

113.07

7.7

7.0

0.82

1.28

mmol/l

2.99

728

2964

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2130

14067

2.11

112.54

7.2

5.5

1.19

1.21

mmol/l

21.85

1981

12527

(3027801) Oxygen [Partial pressure] in Arterial blood

842

3804

2.54

112.53

7.7

7.0

14.88

11.49

kpa

45.03

811

3613

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

842

3805

2.54

112.46

7.7

7.0

5.19

5.05

kpa

4.90

812

3620

(3030467) Casts [#/volume] in Urine by Automated count

1475

8513

2.16

110.75

3.4

3.0

0.53

0.47

e6/l

0.36

1154

6447

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2278

15530

2.09

109.26

8.3

5.9

1.19

1.21

mmol/l

25.45

1957

13139

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

360

1053

3.66

103.96

2.6

3.1

0.29

0.33

u/ml

1.53

180

624

(36304419) Bacteria [Presence] in Urine

1408

8170

2.12

102.54

3.3

2.9

—

(40758558) Short blood count panel - Blood

1237

6829

2.18

102.48

13.5

4.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

548

2095

2.87

101.24

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

529

2004

2.89

99.29

8.2

9.0

95.76

93.31

35.50

529

1995

(3000991) Gas panel - Venous blood

614

2604

2.61

92.13

7.2

7.9

—

(3018095) Leukocytes [#/volume] in Urine

1677

10736

1.97

90.07

4.1

3.5

158.37

114.88

e6/l

0.97

1299

7625

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

442

1603

2.98

89.40

8.5

9.2

24.00

24.37

mmol/l

1.74

435

1536

(3031040) Bacteria [#/volume] in Urine by Automated count

2659

19980

2.00

88.00

4.9

4.4

2553.22

2016.31

e6/l

0.10

321

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

903

4815

2.13

78.72

3.2

2.8

2.43

2.11

e6/l

0.38

511

2650

(3042936) Bacteria identified in Isolate by Culture

797

4295

2.07

66.26

2.3

2.0

—

(3000850) Epithelial cells [#/volume] in Urine

1077

6491

1.90

64.63

2.7

2.5

5.29

4.49

e6/l

0.81

983

5751

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

917

5272

1.96

63.19

3.0

2.6

1.06

1.17

e6/l

0.37

516

3089

(3026782) Osmolality of Urine

1032

6173

1.91

63.15

3.4

2.8

524.30

548.79

mosm/kgh2o

3.58

924

5207

(3026008) Bacteria identified in Urine by Culture

1381

9251

1.75

57.18

3.4

3.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

16.24

52.96

2.5

1.0

16.76

13.52

u/ml

0.45

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

758

4310

1.94

52.88

2.2

2.7

19.99

22.66

5.39

658

3611

(3004789) Transferrin [Mass/volume] in Serum or Plasma

781

4605

1.87

48.28

2.2

2.6

2.36

2.28

g/l

3.16

732

4216

(3022948) Iron [Moles/volume] in Serum or Plasma

829

5000

1.83

47.58

2.3

2.6

11.62

12.82

umol/l

4.21

778

4598

(3020779) Urea [Moles/volume] in Serum or Plasma

550

2933

2.02

45.66

5.0

7.1

9.44

11.08

mmol/l

5.11

526

2771

(3048689) Calprotectin [Mass/mass] in Stool

560

3059

1.97

43.26

1.5

2.2

274.47

164.44

ug/g

4.63

448

2400

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

304

1308

2.43

42.90

1.9

1.8

2.55

1.72

ug/l

0.67

275

1124

(3037467) Urinalysis macro (dipstick) panel - Urine

2576

21190

1.61

42.83

5.5

4.2

—

(3022096) Basophils/100 leukocytes in Blood

1750

13162

1.59

42.64

4.5

5.6

0.56

0.67

13.89

1620

12075

(3006504) Eosinophils/100 leukocytes in Blood

1792

13561

1.58

42.47

4.6

5.6

2.69

2.99

6.05

1663

12450

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

134

5.84

42.33

3.7

1.7

6.46

4.76

nmol/l

0.23

128

(3019069) Monocytes/100 leukocytes in Blood

1799

13637

1.58

42.25

4.9

5.9

9.10

8.85

2.10

1670

12541

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

234

904

2.69

41.30

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3423

30474

1.89

41.15

29.2

13.9

37.08

24.71

mg/l

76.99

3201

23914

(3002030) Lymphocytes/100 leukocytes in Blood

1822

13924

1.57

40.82

4.7

5.8

22.59

26.73

39.57

1688

12846

(3025941) Bacteria identified in Stool by Culture

324

1476

2.30

40.10

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

828

5267

1.72

38.61

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

1787

13780

1.54

37.27

4.5

5.6

61.26

58.18

17.72

1658

12711

(40760892) CBC W Ordered Manual Differential panel - Blood

1766

13589

1.54

37.16

4.9

5.8

—

(3018418) pH of Serum or Plasma

1252

8931

1.59

36.84

5.1

3.3

7.40

0.21

263

1562

(40768800) Prostate Pathology biopsy report

192

4.61

36.62

1.1

—

(3039000) Anion gap in Blood

192

720

2.75

35.88

8.6

7.0

11.01

11.33

mmol/l

0.79

173

638

(3018572) Chloride [Moles/volume] in Blood

192

720

2.75

35.88

8.6

7.0

106.50

104.89

mmol/l

5.37

173

638

(3047181) Lactate [Moles/volume] in Blood

245

1039

2.45

35.59

7.5

6.1

1.37

1.33

mmol/l

0.21

217

916

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

550

3185

1.84

35.07

4.9

3.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1142

8091

1.58

34.07

2.2

2.3

3.30

2.96

mg/l

3.70

963

6826

(3051651) Icteric interference index of Serum or Plasma

144

5.07

34.06

5.0

4.1

—

(3006315) Basophils [#/volume] in Blood

1855

14699

1.49

32.32

4.4

5.3

0.04

e9/l

12.55

1560

12575

(3001604) Monocytes [#/volume] in Blood

1848

14644

1.49

32.12

4.4

5.3

0.61

0.62

e9/l

0.27

1552

12522

(40768441) Liver Pathology biopsy report

102

5.75

31.57

1.0

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

1877

15022

1.47

30.43

4.5

5.4

1.62

1.83

e9/l

2.40

1623

13108

(3008152) Bicarbonate [Moles/volume] in Arterial blood

406

2256

1.89

29.22

8.3

7.1

24.68

24.55

mmol/l

0.29

385

2151

(3013115) Eosinophils [#/volume] in Blood

1886

15221

1.45

28.61

4.5

5.5

0.18

0.21

e9/l

9.81

1620

13173

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

288

1455

2.06

27.26

6.7

4.9

1.65

1.63

0.15

264

1359

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1515

11803

1.46

27.26

2.6

2.9

168.21

143.37

ug/l

1.04

1383

10733

(3019060) Gas panel - Arterial blood

411

2347

1.84

27.07

6.3

4.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

283

1428

2.06

26.87

6.8

4.9

0.91

0.86

1.41

260

1336

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

10.81

26.87

1.4

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

167

681

2.52

26.38

2.1

1.4

32.22

22.28

u/ml

1.02

160

646

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

156

623

2.56

25.74

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

613

3975

1.64

25.52

4.6

5.7

1.02

1.03

mmol/l

0.28

576

3640

(40768795) Lymph node Pathology biopsy report

7.84

25.51

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1626

12955

1.43

25.39

16.1

8.7

0.00

e9/l

0.16

1334

10516

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

111

374

3.02

25.27

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3191

28894

1.53

24.03

30.3

12.9

78.62

75.26

ml/min/173m2

18.16

2879

23366

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

346

1960

1.84

23.29

1.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

490

3135

1.64

21.28

3.0

2.7

259.44

238.03

u/l

1.10

468

2890

(3051611) Lipemic interference index of Serum or Plasma

304

2.97

19.85

4.6

3.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

344

2.83

19.64

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

325

1908

1.77

19.35

1.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

710

5050

1.49

19.18

1.9

30.23

30.10

0.23

696

4885

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

343

2.81

19.17

1.4

1.3

—

(40768793) Breast Pathology biopsy report

120

4.21

19.04

1.4

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

345

2.80

18.97

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

353

2.76

18.73

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

349

2.76

18.57

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

178

874

2.08

18.19

1.9

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

359

2.71

18.14

1.4

1.3

—

(3044889) 12 lead EKG panel

2536

22447

1.36

18.11

4.3

4.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2847

30883

0.72

17.50

4.1

4.8

4.53

4.49

mmol/l

1.05

2565

28358

(3007853) Bacteria identified in Skin by Aerobe culture

526

3593

1.53

17.08

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3468

32497

1.52

17.04

35.1

17.0

139.24

139.79

mmol/l

32.22

3420

31573

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2823

30622

0.73

16.90

4.1

4.8

1.44

1.42

mmol/l

0.80

2527

27928

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

537

3698

1.52

16.78

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3472

32584

1.52

16.49

35.2

17.1

3.95

4.00

mmol/l

31.50

3424

31605

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

317

4944

0.61

15.72

1.2

1.3

56.99

39.93

iu/ml

0.61

100

1502

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2944

31633

0.73

15.52

4.6

5.5

2.64

2.62

mmol/l

0.34

2622

28930

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

297

4688

0.60

15.45

1.2

9.93

14.09

u/ml

0.47

106

1735

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

155

3.45

15.33

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

230

1310

1.80

15.16

2.0

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

528

3714

1.49

14.79

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

5.94

14.77

4.1

2.4

14.13

15.68

ml/dl

1.58

(3013512) EKG study

1227

9972

1.33

14.66

4.2

4.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2746

29721

0.75

14.33

5.9

6.5

40.97

40.90

mmol/mol

0.10

2471

27279

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2118

18606

1.30

14.08

3.5

3.0

63.30

49.90

u/l

5.85

1989

16912

(3021447) Carbon dioxide [Partial pressure] in Venous blood

468

3249

1.50

13.95

3.1

3.6

5.75

5.85

kpa

1.27

450

3144

(3002032) Base excess in Venous blood by calculation

466

3234

1.50

13.91

3.1

3.6

1.89

2.00

mmol/l

0.22

379

2731

(40761511) CBC panel - Blood by Automated count

3357

31525

1.42

13.68

28.7

13.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

404

2.36

13.39

5.6

6.5

12.43

12.09

mg/l

0.22

363

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2747

29630

0.76

13.08

3.7

4.3

1.30

mmol/l

0.06

2428

26774

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

1214

1.76

12.91

1.9

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

369

2487

1.53

12.62

4.6

3.1

1.22

mmol/l

1.56

328

2121

(3019225) pH of Specimen

455

3207

1.47

12.53

4.2

3.8

—

(3052851) Hemolysis interference index of Serum or Plasma

163

887

1.87

12.48

4.8

3.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2539

23009

1.29

12.44

3.3

4.1

16.98

12.61

mm/h

24.83

2318

21081

(3027945) Reticulocytes/100 erythrocytes in Blood

526

3829

1.43

12.19

2.2

2.1

1.72

1.76

0.43

466

3328

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

247

1535

1.65

11.92

2.8

4.0

24.11

24.18

mmol/l

0.11

241

1495

(3049717) Cytology report of Urine Cyto stain

190

1112

1.74

11.46

2.7

1.8

—

(40761536) Microorganisms panel - Urine sediment

343

2323

1.52

11.46

4.6

3.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

213

1288

1.69

11.42

4.6

4.2

1.27

1.43

mmol/l

1.04

204

1264

(3014765) Yersinia sp identified in Stool by Organism specific culture

153

846

1.84

11.17

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

343

2346

1.51

10.93

3.2

3.8

1.08

0.80

1.52

146

627

(42529406) Shigella sp [Presence] in Stool by Culture

153

852

1.83

10.93

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

275

1792

1.57

10.93

2.4

2.5

—

(3037522) Nuclear Ab [Titer] in Serum

255

3859

0.64

10.85

1.2

1.3

501.33

524.96

titre

0.06

824

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3440

32700

1.38

10.78

19.0

9.4

24.07

25.81

u/l

9.04

3368

31198

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

151

842

1.82

10.75

1.2

—

(3012501) Base excess in Blood by calculation

130

693

1.90

10.65

4.3

4.5

2.68

2.65

mmol/l

0.05

460

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

127

678

1.90

10.37

2.3

2.1

214.13

194.61

1.58

122

642

(3002385) Erythrocyte distribution width [Ratio]

2783

25741

1.27

10.36

37.8

16.0

15.70

15.33

2.93

2758

25142

(3004809) Band form neutrophils/100 leukocytes in Blood

380

2.21

10.28

2.8

3.1

2.89

1.42

1.71

320

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2062

22722

0.81

9.86

3.1

3.7

15.06

14.97

pmol/l

0.89

1806

20293

(3021440) Promyelocytes/100 leukocytes in Blood

327

2263

1.48

9.84

3.3

3.8

0.18

0.07

1.94

131

544

(3010421) pH of Blood

145

822

1.79

9.80

4.1

4.4

7.42

0.52

132

735

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

688

8611

0.76

9.77

1.6

1.47

1.35

mmol/l

1.11

559

7131

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

133

3.03

9.52

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

133

3.03

9.52

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

9.38

1.0

0.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

114

3.18

9.30

1.8

2.6

—

(1616796) Gas panel - Central venous blood

126

697

1.83

9.25

3.7

3.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

180

2.69

9.20

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

120

661

1.84

8.94

2.0

2.5

34.32

35.13

umol/l

0.12

110

583

(3003434) Protein [Mass/volume] in Pleural fluid

384

2.10

8.86

1.4

1.5

30.52

28.40

g/l

0.69

331

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

193

1220

1.61

8.76

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

185

2.61

8.74

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.73

8.60

2.7

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

372

2706

1.41

8.59

2.8

3.0

4.62

4.52

kpa

0.32

354

2607

(3020891) Body temperature

219

1438

1.55

8.46

5.3

5.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.75

8.33

1.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

306

2168

1.45

8.17

3.1

3.6

0.68

0.62

0.23

126

556

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

352

2566

1.41

8.03

4.4

2.3

62.80

62.59

ml/min/173m2

0.03

140

990

(3025159) Blasts/100 leukocytes in Blood

304

2165

1.44

7.90

3.4

3.9

0.55

0.06

0.49

110

455

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

302

2149

1.44

7.88

3.1

3.6

5.10

5.16

kpa

0.68

282

2009

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

290

2051

1.45

7.82

3.1

3.6

2.25

1.83

mmol/l

1.04

212

1483

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

123

2.86

7.62

1.8

1.5

—

(3012441) Differential panel - Pleural fluid

287

2.18

7.58

1.5

—

(3009343) pH of Capillary blood

296

2120

1.43

7.47

3.1

3.6

7.43

7.42

0.46

257

(3021601) Nitrite [Presence] in Urine by Test strip

1677

14998

1.20

7.38

5.5

4.9

0.00

estimate

-0.00

380

2554

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.27

7.37

1.4

0.99

2.51

1.28

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

358

2.03

7.32

1.1

1.65

1.53

g/l

1.65

312

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

7.29

1.0

0.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

177

1147

1.57

7.29

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.92

7.09

8.7

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

383

2893

1.36

7.04

2.3

2.2

66.04

68.23

e9/l

0.63

289

2220

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

245

2.22

6.96

1.3

1509.86

271.74

u/l

0.49

230

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

165

2.50

6.91

1.8

2.00

1.84

u/field

0.09

112

(3009261) Glucose [Presence] in Urine by Test strip

1688

15171

1.20

6.88

4.2

3.7

0.00

estimate

1.34

375

2441

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

440

1.88

6.73

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

694

5716

1.26

6.70

1.1

1.2

1.36

2.06

u/ml

0.99

182

1495

(4281824) Cell count and differential, peritoneal fluid

138

2.62

6.70

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2931

30751

0.82

6.69

4.4

5.0

6.14

6.09

mmol/l

0.96

2604

27711

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

928

10802

0.82

6.67

2.1

2.2

198.97

234.07

u/l

0.66

878

10048

(40768806) Pleura Pathology biopsy report

264

2.14

6.59

1.4

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

3496

33735

1.30

6.58

45.0

20.5

37.99

40.42

35.71

3300

30945

(3003327) Ova and parasites identified in Stool by Light microscopy

130

804

1.64

6.53

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

1671

15055

1.19

6.51

4.1

3.7

0.00

estimate

1.94

396

2781

(3000963) Hemoglobin [Mass/volume] in Blood

3497

33776

1.29

6.30

45.0

20.5

126.73

136.61

g/l

233.40

3456

33098

(3024731) MCV [Entitic volume]

3496

33766

1.29

6.30

44.6

20.3

91.31

91.57

2.45

3456

33084

(3010813) Leukocytes [#/volume] in Blood

3496

33768

1.29

6.28

44.7

20.4

6.71

6.79

e9/l

0.87

3414

32520

(3035941) MCH [Entitic mass]

3496

33769

1.29

6.27

44.6

20.3

30.15

30.50

22.44

3455

33090

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

114

2.73

6.26

1.4

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

3496

33770

1.29

6.26

44.7

20.4

4.26

4.50

e12/l

139.30

3413

32521

(3007461) Platelets [#/volume] in Blood

3495

33760

1.29

6.25

44.8

20.4

249.24

240.55

e9/l

10.05

3421

32663

(3036489) Thrombin time

152

988

1.56

6.23

2.0

1.8

20.87

21.20

0.50

146

866

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

105

623

1.70

6.19

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.06

6.18

1.4

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.02

6.06

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.02

6.06

1.4

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

101

597

1.71

6.05

1.3

1.4

—

(4200892) Spirometry reversibility

165

2418

0.67

6.01

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

309

2315

1.36

6.01

1.3

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

591

4842

1.26

5.94

1.3

2.54

2.70

g/l

0.84

322

2768

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

489

1.77

5.91

4.1

3.5

60.02

58.91

0.32

489

(1002224) Polysomnography panel

992

0.50

5.86

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

111

680

1.65

5.83

2.7

2.5

15.38

16.30

1.22

365

(3023199) Leukocytes [#/volume] in Pleural fluid

347

1.92

5.81

1.5

858.98

2281.58

e6/l

1.52

255

(3021901) Oxygen saturation in Capillary blood

103

621

1.68

5.75

2.9

2.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

114

2.64

5.72

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

197

1385

1.44

5.56

2.3

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

313

1.93

5.43

1.4

1.5

19889.25

73819.68

e6/l

1.20

183

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

313

1.93

5.43

1.3

1.4

174.25

66.87

pmol/l

0.58

303

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1482

13364

1.17

5.41

3.6

4.0

65.65

81.38

ng/l

0.17

1171

9984

(3020682) Albumin/Creatinine [Ratio] in Urine

1046

11842

0.84

5.33

4.0

3.8

9.69

8.36

mg/mmol

0.46

671

7556

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

5.21

1.0

0.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

785

6751

1.20

4.91

3.4

4.1

689.56

505.67

ng/l

0.38

654

5711

(3017143) Hepatitis C virus Ab [Presence] in Serum

289

2218

1.33

4.83

1.3

1.5

—

(3000012) Reticulocyte production index

437

1.73

4.81

2.1

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

182

2.15

4.80

1.4

1.2

15.71

10.52

u/l

0.34

162

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1225

10969

1.17

4.75

2.6

3.1

1455.42

1610.28

ng/l

0.73

1080

9453

(3045788) Cell count panel - Pleural fluid

258

1.95

4.72

1.5

—

(3045142) Bone marrow Pathology biopsy report

218

2.03

4.65

1.1

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

764

8790

0.84

4.57

2.5

3734.31

5772.82

umol/l

0.76

656

7520

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

105

679

1.56

4.50

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

105

679

1.56

4.50

1.2

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

105

2.49

4.45

1.4

55.25

64.30

0.44

(3009508) Creatinine [Moles/volume] in Urine

1017

11401

0.85

4.42

3.3

3.2

7.59

7.57

mmol/l

0.05

807

9527

(3012516) Albumin [Mass/volume] in Urine

998

11203

0.85

4.41

3.3

3.2

354.94

239.01

mg/l

0.40

671

7260

(4094501) Cardiovascular stress test using bicycle ergometer

935

0.56

4.32

1.0

1.1

—

(3035880) pH of Pleural fluid

151

2.19

4.29

1.2

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

125

849

1.49

4.29

1.3

1.4

256.46

286.68

ug/g

0.92

516

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2698

28196

0.86

4.29

3.8

4.5

2.02

2.06

mu/l

0.35

2369

25367

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

209

1557

1.36

4.29

1.6

1.5

1.72

1.55

g/l

1.62

180

1340

(3022313) Gas panel - Capillary blood

207

1544

1.36

4.22

3.0

3.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1100

0.60

4.17

1.1

1.2

7.40

0.82

u/ml

—

111

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

986

0.58

4.14

1.1

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

102

669

1.54

4.14

1.7

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

257

1.88

4.11

2.4

2.8

56.36

59.12

0.36

207

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1106

0.61

4.08

1.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

116

2.34

4.07

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

116

2.34

4.07

1.4

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

579

1.57

3.99

1.3

1.5

—

(3045424) Erythrocytes [Presence] in Urine

502

1.61

3.94

1.9

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

114

1646

0.68

3.94

1.2

1.3

236.16

234.68

u/ml

0.01

102

1514

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

179

1326

1.37

3.84

3.1

3.9

25.02

24.77

mmol/l

0.49

160

1201

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

124

1752

0.70

3.81

1.2

1.3

103.62

61.13

au/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

222

1.90

3.76

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

935

8328

1.16

3.76

4.3

4.1

0.01

0.00

estimate

0.35

333

2467

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

760

1.47

3.71

2.6

2.2

123.01

130.55

g/l

2.37

566

(3009466) Valproate [Moles/volume] in Serum or Plasma

476

0.44

3.70

3.5

4.4

319.23

351.00

umol/l

0.34

404

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

283

1.78

3.63

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

225

1.88

3.63

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

225

1.88

3.63

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

225

1.88

3.63

1.3

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

233

1818

1.30

3.53

3.3

3.1

24.60

25.22

mmol/l

1.43

220

1751

(3041096) Erythrocytes [Presence] in Urine by Automated

858

7626

1.16

3.53

4.6

3.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

301

1.74

3.51

2.8

3.0

—

(4034850) Laboratory test

1170

0.65

3.48

13.1

10.1

—

(3014051) Protein [Presence] in Urine by Test strip

118

832

1.43

3.41

3.0

2.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1200

0.66

3.40

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

143

1933

0.73

3.40

2.3

2.4

56.26

23.76

au/ml

—

101

(3032773) Endomysium IgG Ab [Titer] in Serum

209

1.87

3.39

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

242

3037

0.78

3.36

1.4

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

277

2226

1.26

3.33

2.7

3.2

122.60

130.64

g/l

7.28

268

2161

(3008898) HLA-B27 [Presence]

717

0.57

3.32

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

998

0.64

3.28

1.2

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

270

1.75

3.28

3.4

—

(3017732) Neutrophils [#/volume] in Blood

247

1963

1.27

3.26

4.9

3.1

4.26

5.69

e9/l

2.53

201

1457

(3002619) Bacteria identified in Specimen by Culture

2.86

3.18

1.4

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

412

1.59

3.14

1.8

89.08

89.60

0.25

405

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

151

1.99

3.14

1.4

—

(1761868) Lipid panel - Serum or Plasma

867

9626

0.87

3.13

2.9

3.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

4.51

3.11

1.1

19.36

16.47

g/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

152

1.98

3.09

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

847

0.62

3.05

1.4

1.6

1.19

3.65

iu/ml

0.34

192

(3033799) Differential panel - Peritoneal fluid

2.44

3.04

2.3

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

408

1.58

3.03

1.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

408

1.58

3.03

1.2

1.4

—

(40765096) Chromosome analysis panel by Banding

3.34

3.01

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

101

713

1.43

2.95

1.6

3.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

212

1.80

2.95

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

333

2773

1.22

2.92

1.3

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

639

0.57

2.91

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

666

1.44

2.89

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.43

2.87

1.3

922.29

5.23

ug/l

0.56

(3021879) Hepatitis B virus core Ab [Presence] in Serum

173

1337

1.31

2.87

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

645

0.59

2.81

1.1

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1.85

2.81

1.3

—

(3044007) Cell count panel - Peritoneal fluid

2.47

2.78

1.1

2.3

—

(3019977) pH of Arterial blood

187

1.82

2.78

1.6

2.2

7.42

7.43

0.45

(3000475) Leukocytes [#/volume] in Synovial fluid

899

0.65

2.77

1.4

1.5

7542.21

14290.29

e6/l

1.21

653

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

101

1388

0.72

2.73

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

429

1.52

2.69

1.2

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.33

2.64

1.2

2.5

27360.20

32309.87

e6/l

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.21

2.63

1.2

2.8

509.67

625.89

e6/l

0.14

(3019150) Specific gravity of Urine by Refractometry

629

7045

0.87

2.55

4.1

1.02

kg/l

0.13

108

1040

(3029396) Erythrocyte agglutination [Presence] in Blood

7.15

2.55

1.4

1.9

—

(21494755) Public health laboratory ask at order entry panel

126

1655

0.75

2.54

1.2

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.98

2.48

1.5

1.1

0.80

2.73

ug/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

875

0.67

2.46

1.4

1.8

41.57

43.27

nmol/l

0.31

834

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

279

1.62

2.45

1.8

2.1

2.14

1.84

u/field

0.18

(3045683) HLA typing for celiac disease panel - Blood or Tissue

116

1.99

2.45

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

861

0.67

2.44

1.3

1.6

3.03

4.31

mg/l

0.62

632

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.15

2.34

3.9

2.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

500

0.58

2.33

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

153

0.33

2.27

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.62

2.27

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

170

0.35

2.27

1.0

2.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.56

2.26

2.3

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

309

1.56

2.26

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.89

2.25

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

194

1.71

2.22

2.1

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

2.22

0.0

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.24

2.17

1.4

2.0

11.92

14.42

g/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.62

2.14

1.0

1.1

82.64

139.87

ng/l

—

(36660697) Celiac disease serology panel - Serum

249

2086

1.21

2.13

1.1

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

379

1.48

2.12

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

251

1.60

2.12

1.8

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

479

1.43

2.10

1.2

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

112

1447

0.77

2.06

1.2

187.28

130.56

iu/ml

0.61

533

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

176

1.71

2.05

2.6

1.5

183.45

2057.68

u/l

0.66

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

277

1.56

2.05

1.0

1.1

3.46

2.22

u/ml

0.39

100

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

375

1.47

2.02

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.34

1.96

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2.03

1.95

7.4

1.1

23.12

54.72

u/ml

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

218

1.61

1.93

1.6

1.7

93.34

92.12

umol/l

0.07

218

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

268

0.48

1.92

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

280

3252

0.85

1.89

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

566

0.65

1.87

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

393

0.58

1.85

1.3

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

647

0.68

1.84

1.3

1.4

341.47

777.23

e6/l

0.93

540

(3044242) Glucose [Moles/volume] in Arterial blood

190

1.64

1.83

2.1

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

646

0.68

1.83

1.2

1.3

5.50

25.47

e6/l

1.18

513

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

1.66

1.82

2.3

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

404

4551

0.87

1.81

11.3

7.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

922

0.73

1.79

1.2

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

391

1.41

1.68

1.2

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

666

1.31

1.67

1.0

1.1

1.50

8.75

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

713

0.71

1.65

1.2

2.79

5.88

u/ml

—

119

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

316

0.57

1.63

1.2

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

875

8136

1.10

1.63

1.6

20.18

20.24

nmol/l

0.04

747

6874

(3011397) Hemoglobin [Presence] in Urine by Test strip

805

7458

1.10

1.62

3.2

3.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

133

0.38

1.61

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

237

0.50

1.60

1.2

1.3

196.71

203.92

pmol/l

0.06

237

(4146454) Self-monitoring of blood glucose

412

1.39

1.60

3.3

2.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

349

0.60

1.56

1.2

1.3

123941.33

246181.85

e6/l

0.54

242

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

324

0.58

1.56

1.2

1.1

1.29

1.33

u/ml

—

157

(1001926) Buprenorphine [Presence] in Urine by Screen method

273

0.55

1.55

1.0

1.8

—

(3015736) pH of Urine

1279

12111

1.08

1.55

3.5

5.78

0.02

585

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.54

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

273

1.47

1.53

1.8

1.4

—

(3011648) Oxygen content in Venous blood

257

1.48

1.52

1.2

2.0

11.62

11.09

0.34

257

(3014891) Appearance of Pleural fluid

2.22

1.46

1.8

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1223

0.80

1.45

1.6

1.7

37.02

37.97

u/l

0.17

1024

(3024263) Appearance of Synovial fluid

201

0.50

1.43

1.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

682

0.73

1.43

1.4

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

448

0.67

1.42

1.3

1.5

60.07

61.11

0.04

295

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1152

0.79

1.41

1.7

1.6

228.00

290.17

titre

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

157

1.60

1.40

1.5

1.3

49.69

34.36

u/l

0.83

106

(1761482) Bacteria [#/volume] in Urine by Culture

115

937

1.23

1.39

4.9

4.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

780

0.75

1.38

1.6

1.7

—

(3042631) Mycobacterium sp identified in Specimen

407

1.36

1.37

1.8

3.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.61

1.36

1.0

1.1

—

5.38

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

334

0.63

1.34

1.4

1.5

38.13

27.65

0.47

218

(3021788) Differential panel - Synovial fluid

651

0.73

1.34

1.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

291

1.41

1.32

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

332

0.63

1.31

1.0

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

158

1858

0.84

1.31

1.7

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

1.31

0.0

1.7

—

(3022621) pH of Urine by Test strip

241

2112

1.15

1.30

3.3

3.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

902

0.78

1.26

1.4

1.6

—

(3028300) Cannabinoids [Presence] in Urine

352

0.65

1.25

1.0

1.9

—

(3027008) Opiates [Presence] in Urine

351

0.65

1.24

1.0

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.22

1.24

1.9

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

278

0.61

1.24

1.1

6.87

3.99

u/ml

—

125

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.86

1.23

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

988

0.80

1.23

2.6

2.1

165.27

115.23

ug/min

0.32

577

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.70

1.23

1.5

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.70

1.23

1.5

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

381

1.34

1.23

1.2

1.3

—

(3014271) Vancomycin [Susceptibility]

204

1.47

1.22

3.1

3.0

—

(3011288) Drugs identified in Urine by Screen method

227

0.57

1.22

1.0

2.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.63

1.21

1.0

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

349

0.66

1.21

1.0

1.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.83

1.19

1.3

1.4

17.86

29.41

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.31

1.18

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.31

1.18

10.3

10.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

274

0.62

1.18

1.1

1.77

0.83

u/ml

—

106

(3024869) Neuronal Ab [Presence] in Serum

1.88

1.17

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1149

12043

0.94

1.16

3.8

20.13

24.37

16.81

530

5926

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

1.16

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

130

0.46

1.15

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.15

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

1.15

0.0

1.0

—

(3027944) Amphetamines [Presence] in Urine

343

0.67

1.13

1.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

528

1.27

1.12

3.0

3.4

—

(3000494) Fungus identified in Specimen by Culture

382

3480

1.11

1.12

1.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

693

6488

1.08

1.12

1.6

1.7

2.23

1.28

mg/l

4.10

567

5019

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

159

1.51

1.11

1.3

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

281

0.64

1.10

1.2

1.3

—

27.50

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.26

1.10

3.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

232

0.60

1.10

1.1

—

(3036603) Volume of Urine

176

1.48

1.10

1.7

1.3

1879.96

1891.11

0.03

166

(3014133) Dog dander IgE Ab [Units/volume] in Serum

207

0.58

1.09

1.2

1.1

5.97

2.46

u/ml

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

207

0.58

1.09

1.3

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.38

1.09

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

0.59

1.09

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

193

1.45

1.08

2.0

2.1

64.75

227.46

ug/min

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

0.55

1.08

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

202

1776

1.14

1.08

5.8

3.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

749

0.78

1.07

1.6

1.8

10.74

11.88

mg/l

0.53

687

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

364

3318

1.11

1.07

2.3

3.1

229.94

228.05

ng/l

0.03

330

3048

(3023430) Cat dander IgE Ab [Units/volume] in Serum

192

0.57

1.05

1.2

1.1

4.04

2.97

u/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

122

0.49

1.05

1.2

1.9

19.80

82.26

ug/l

—

113

(3044290) Cell count panel - Cerebral spinal fluid

589

0.76

1.04

1.2

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

921

0.81

1.03

2.6

1.5

0.00

g/l

-0.00

840

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.63

1.03

1.3

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.06

1.02

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

335

0.68

1.02

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

1274

0.84

0.99

2.2

1.4

10.09

10.29

g/l

0.21

1101

(3020876) Protein [Mass/time] in 24 hour Urine

361

1.31

0.98

2.8

2.1

0.73

1.43

g/24h

2.26

177

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

572

0.77

0.98

1.7

1.8

6.62

4.73

iu/l

0.25

178

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

320

0.69

0.98

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.97

0.0

1.1

—

(3000492) Spirometry study

242

2692

0.89

0.97

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

1.1

—

80.35

—

(3052592) Norovirus Ag [Presence] in Stool

1.74

0.96

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

305

0.69

0.94

1.1

—

1.40

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

1363

0.85

0.94

2.4

1.4

3.60

3.76

g/l

0.71

1197

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

715

1.21

0.93

2.4

2.7

1.82

1.73

mg/l

0.40

632

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1015

0.83

0.91

2.8

1.4

0.01

0.03

g/l

1.09

920

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

159

1.45

0.91

1.3

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

938

0.83

0.90

2.6

1.4

0.00

g/l

-0.00

844

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

104

0.48

0.88

1.0

1.1

642.20

1742.22

miu/ml

—

104

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

1366

0.86

0.88

2.4

1.4

7.21

7.47

g/l

1.00

1200

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

1366

0.86

0.88

2.4

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

181

0.61

0.87

1.5

1.1

—

(3044941) Cell count panel - Synovial fluid

582

0.79

0.86

1.2

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

310

0.71

0.85

1.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

273

1.32

0.85

1.1

—

(3023419) Bacteria identified in Sputum by Culture

535

0.78

0.84

2.0

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

0.60

0.83

1.9

2.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

138

0.58

0.83

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

284

0.70

0.82

1.2

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

138

1.45

0.81

1.0

1.1

78.45

83.77

u/l

0.15

124

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1076

0.85

0.80

2.3

1.4

37.82

37.75

g/l

0.04

911

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

398

4270

0.92

0.79

4.3

5.0

32.64

32.84

0.13

251

2869

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.6

—

0.73

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

2.7

—

1.11

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1540

14946

1.05

0.78

4.6

3.9

2.51

2.02

ug/l

1.63

1322

13392

(3035320) C reactive protein [Mass/volume] in Body fluid

208

1.35

0.77

2.5

2.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

405

0.76

1.1

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

115

1.48

0.76

1.4

2.1

15.65

17.28

0.25

109

(3003181) Sodium [Moles/volume] in Urine

576

1.20

0.76

1.5

1.4

65.78

62.20

mmol/l

0.26

462

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1481

14369

1.05

0.76

2.1

85.99

93.43

pmol/l

7.86

862

7502

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

107

1.50

0.76

1.4

2.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.52

0.75

1.7

2.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

395

1.24

0.75

1.7

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.60

0.74

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

266

0.71

0.73

1.3

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

289

0.72

0.73

1.1

—

25.86

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.52

0.72

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

230

0.69

0.72

1.1

2.90

1.24

u/ml

—

111

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

281

3041

0.92

0.71

1.5

1.8

1.62

1.56

0.41

243

2583

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.55

0.69

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.55

0.69

1.2

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1134

0.87

0.69

2.6

1.5

0.61

0.43

g/l

0.48

966

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.53

0.68

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.53

0.68

1.2

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

1281

0.88

0.68

2.4

1.4

2.92

g/l

0.01

1117

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

307

0.75

0.68

1.8

1.7

45.20

25.32

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

121

0.58

0.67

1.1

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

821

0.85

0.67

1.3

1.5

0.24

g/l

0.17

778

(1175426) CD3 cells/100 lymphocytes in Blood

119

1.43

0.66

1.4

2.1

72.65

73.19

0.05

109

(3025130) Human papilloma virus identified in Specimen

162

1.36

0.66

1.4

1.9

—

(4062490) Immunoglobulin typing, IgG

282

0.74

0.65

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

130

0.61

0.63

1.4

1.2

157.37

173.04

mmol/24h

—

130

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

432

1.21

0.63

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

859

0.86

0.63

1.5

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

153

0.65

0.62

1.0

1.2

128.30

140.97

nmol/l

—

153

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

674

0.84

0.61

1.1

1.5

1.21

0.80

nmol/l

1.27

549

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.60

0.61

1.8

2.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

139

1.37

0.60

1.0

1.1

28.74

24.71

u/l

0.14

123

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.9

—

1.05

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.50

0.59

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

377

0.79

0.59

1.1

1.2

218.32

283.24

u/ml

0.98

233

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.56

0.58

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.58

0.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

1.51

0.58

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

321

0.78

0.58

2.1

2.3

685.38

622.22

0.55

211

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

0.60

0.57

1.1

1.2

49.67

58.26

—

102

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.48

0.57

1.3

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

230

0.74

0.57

1.2

2.66

2.15

mmol/l

0.73

216

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.67

0.56

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

274

1.24

0.56

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.45

0.56

1.0

1.9

35.25

25.86

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.45

0.56

1.0

2.0

13.75

7.81

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.56

1.2

1.4

10.62

9.30

ug/l

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.48

0.53

1.7

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1196

11635

1.04

0.53

4.6

3.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

160

1.31

0.53

2.4

1.8

—

(3020650) Glucose [Presence] in Urine

1.52

0.52

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

843

0.88

0.52

1.4

1.5

1.12

1.17

g/l

0.68

795

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

203

0.74

0.51

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

203

0.74

0.51

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

203

0.74

0.51

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

248

0.76

0.51

1.1

—

(3048879) Bone marrow aspiration report

1.47

0.50

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

407

1.18

0.50

1.5

2.1

56.27

25.40

mg/l

0.82

(3027135) IgG subclass 1 [Mass/volume] in Serum

280

0.78

0.50

1.4

5.87

6.88

g/l

0.61

203

(3024139) IgG subclass 3 [Mass/volume] in Serum

280

0.78

0.50

1.4

0.34

0.41

g/l

0.59

203

(3028192) IgG subclass 2 [Mass/volume] in Serum

280

0.78

0.50

1.4

2.23

3.01

g/l

1.92

201

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

189

1.27

0.49

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

207

1.26

0.49

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

432

0.83

0.48

1.4

1.7

0.73

0.92

g/l

0.37

331

(3006922) Hepatitis E virus Ab [Presence] in Serum

145

1.31

0.48

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

109

0.64

0.48

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

200

0.75

0.47

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

200

0.75

0.47

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

200

0.75

0.47

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

190

1.26

0.47

2.9

2.0

—

17.36

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.49

0.47

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

473

0.84

0.47

1.0

1.1

160.73

427.24

iu/ml

0.33

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

374

1.18

0.46

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.61

0.45

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.60

0.45

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

406

0.84

0.45

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.45

0.44

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

620

1.13

0.44

1.3

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

735

0.88

0.43

3.7

30.15

28.10

mg/l

0.15

478

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

2003

0.93

0.43

1.1

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

117

1069

1.10

0.43

2.7

1.5

34.96

35.45

mg/l

0.05

867

(3004588) Protein electrophoresis panel - Serum or Plasma

224

2383

0.94

0.42

2.3

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

239

1.21

0.42

1.3

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.65

0.42

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.65

0.42

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.65

0.42

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.65

0.42

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

793

1.11

0.42

2.5

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.64

0.42

1.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.40

0.42

1.4

1.5

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

0.14

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.47

0.40

2.4

2.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.47

0.40

1.8

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.47

0.40

2.4

2.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.47

0.40

1.0

1.2

18.80

14.72

u/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

368

0.84

0.39

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.34

0.39

1.2

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.43

0.39

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.39

0.0

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

340

3559

0.95

0.38

1.9

2.4

5.66

7.56

ug/l

1.79

291

3116

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

115

1.31

0.38

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.36

0.38

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

811

8329

0.97

0.37

3.0

2.7

0.71

ug/l

0.01

559

5755

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

188

1.22

0.37

1.1

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

114

1052

1.09

0.36

2.0

2.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

168

0.77

0.35

1.1

—

(40757373) Influenza virus identified in Isolate

0.64

0.35

1.2

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

116

1072

1.08

0.35

2.7

1.5

53.16

48.77

mg/l

0.30

874

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.31

0.35

5.8

7.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.40

0.35

2.5

2.6

0.67

0.37

u/field

—

(3044927) Protein electrophoresis panel - Urine

405

0.86

0.34

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.36

0.34

1.8

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

468

0.87

0.34

1.4

1.7

248.36

293.63

mu/l

0.81

432

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.34

0.34

2.8

2.2

8.80

8.11

mmol/l

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

252

2399

1.05

0.33

1.9

1.8

405.67

368.02

nmol/l

2.41

231

2159

(44813793) Dust mix specific IgE antibody measurement

166

0.78

0.33

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.30

0.33

1.3

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

381

0.86

0.32

1.2

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

359

0.86

0.32

1.2

1.3

—

nmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

137

1.24

0.32

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

137

1.24

0.32

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

316

0.85

0.31

1.1

—

u/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

580

0.89

0.31

1.1

1.2

108.26

24.09

u/l

0.65

500

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

432

0.88

0.31

1.2

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

112

1042

1.08

0.30

2.8

1.5

1.41

2.67

ratio

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

100

0.70

0.30

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

639

1.10

0.29

1.6

1.2

—

(3022689) Creatine [Moles/volume] in Urine

106

0.75

0.29

1.3

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

0.74

0.29

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

234

2447

0.95

0.28

3.3

3.8

96.95

97.82

ng/l

0.04

191

2063

(3019420) Tryptase [Mass/volume] in Serum or Plasma

110

0.73

0.28

1.0

1.7

3.39

8.99

ug/l

—

(3047189) Immunofixation for 24 hour Urine

121

1.24

0.28

1.6

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.25

0.28

1.9

2.2

92.71

95.38

0.10

103

(3034274) Bile acid [Moles/volume] in Serum --fasting

112

1.25

0.28

1.9

1.2

17.97

8.14

umol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

129

0.77

0.28

2.0

2.2

56.90

56.38

umol/l

—

109

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.29

0.28

5.5

7.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

150

0.80

0.27

1.1

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

204

0.83

0.27

1.3

1.2

0.20

1.21

u/ml

1.23

116

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.70

0.26

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.69

0.26

1.4

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.30

0.26

1.2

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.68

0.26

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

291

1.13

0.26

1.3

1.4

273.70

279.01

mosm/kgh2o

0.81

216

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.67

0.25

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

404

0.89

0.25

1.1

1.2

228.88

191.26

miu/ml

—

151

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.25

0.25

1.2

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

138

0.80

0.25

1.7

1.5

—

(3006270) Folate [Moles/volume] in Blood

319

0.88

0.25

1.3

1.2

340.69

346.38

nmol/l

0.05

256

(3020630) Protein [Mass/volume] in Serum or Plasma

286

2758

1.04

0.24

2.5

1.6

64.50

66.75

g/l

4.75

257

2440

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.25

0.24

3.3

2.2

34.43

44.79

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.17

0.24

1.0

2.1

—

34861.92

—

(3020491) Glucose [Moles/volume] in Blood

254

0.87

0.23

1.4

2.4

7.12

6.83

mmol/l

0.20

167

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

0.82

0.23

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

217

2084

1.04

0.23

1.9

2.2

10.83

14.70

nmol/l

8.19

183

1826

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

400

0.90

0.22

1.3

1.4

252.12

303.61

pmol/l

0.69

340

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

515

1.09

0.22

1.4

—

(3034426) Prothrombin time (PT)

0.75

0.22

1.1

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.75

0.22

6.0

1.6

230.14

161.40

—

(3004451) EKG impression Narrative

181

1.16

0.22

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

419

1.10

0.22

1.1

—

(3025577) Chromium [Mass/volume] in Blood

263

0.87

0.22

2.0

2.29

1.81

ug/l

0.37

221

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

295

1.12

0.22

1.1

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

295

1.12

0.22

1.1

1.4

—

(21494434) Karyotype in Bone marrow

238

1.14

0.22

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.22

0.22

1.2

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.2

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

101

0.79

0.21

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

635

0.93

0.20

1.1

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

202

1.14

0.20

6.7

10.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

469

0.92

0.20

1.3

22.51

8.92

u/l

3.34

378

(40768443) Skin Pathology biopsy report

117

1228

0.95

0.19

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

147

1.16

0.18

4.5

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

145

1507

0.96

0.17

1.8

1.4

1.31

1.15

g/l

0.40

132

1360

(3016650) Hepatitis A virus Ab [Presence] in Serum

349

1.09

0.17

1.0

—

(3011985) Renin [Units/volume] in Plasma

423

0.92

0.17

1.4

40.83

58.79

mu/l

0.78

377

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

495

0.93

0.16

1.3

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.18

0.16

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.13

0.16

5.3

7.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.78

0.15

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.77

0.15

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.76

0.15

1.0

1.1

—

(40761535) Cells panel - Urine sediment

285

2920

0.97

0.15

3.0

3.3

—

(40768446) Kidney Pathology biopsy report

119

0.84

0.15

1.4

1.6

—

(3028433) Virus identified in Specimen by Culture

0.78

0.14

1.4

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

150

1.13

0.14

1.2

1.5

—

(3017704) Immunofixation for Urine

191

0.89

0.14

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

170

0.88

0.13

2.9

4.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

103

1.17

0.13

1.2

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

325

1.08

0.13

3.1

3.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

108

0.83

0.13

1.4

1.9

87.73

49.73

ug/l

—

103

(3033705) Calcium.ionized [Moles/volume] in Venous blood

462

1.06

0.12

3.5

2.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

423

1.06

0.12

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

133

1.13

0.12

1.1

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

199

0.90

0.11

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

526

0.95

0.11

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.11

0.09

15.0

13.4

5.56

5.00

mmol/l

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

428

1.05

0.09

1.2

1.3

44.76

31.53

iu/l

1.64

371

(3016750) Collection duration of Urine

217

0.92

0.09

2.1

2.0

487.71

496.00

min

0.12

162

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.04

0.09

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

708

7142

0.99

0.09

1.7

1.8

1148.29

1150.47

nmol/l

0.02

530

5357

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1538

15297

1.01

0.09

2.2

2.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.83

0.08

1.6

1.4

94.40

139.31

ng/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

1.10

0.08

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1241

12339

1.01

0.08

2.1

2.2

75.95

78.55

nmol/l

2.33

1083

10757

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

127

1.10

0.07

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.04

0.07

2.4

1.8

—

(40768797) Stomach Pathology biopsy report

424

4195

1.01

0.07

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.83

0.07

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

101

0.89

0.06

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

104

0.86

0.06

1.6

3.2

18.30

22.79

mu/l

—

(3038026) Centromere Ab [Units/volume] in Serum

254

0.94

0.06

1.1

1.2

—

67.95

—

(21494890) Protein electrophoresis panel - 24 hour Urine

315

1.05

0.06

2.6

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

182

0.93

0.05

1.3

1.15

1.20

nmol/l

0.08

139

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

395

0.96

0.05

1.3

1.2

5.33

3.37

u/ml

0.28

115

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

142

1397

1.02

0.05

3.3

2.9

4.34

4.40

pmol/l

0.26

131

1198

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

202

0.94

0.05

1.2

1.5

15.34

14.13

umol/l

0.24

185

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

139

1.08

0.05

1.3

0.57

0.23

nmol/l

—

110

(3026389) Candida sp identified in Specimen by Organism specific culture

364

0.96

0.05

1.0

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

192

1895

1.01

0.05

2.7

2.2

9.64

10.80

g/l

4.09

174

1730

(3027456) Digoxin [Moles/volume] in Serum or Plasma

832

1.02

0.05

3.0

3.2

0.83

nmol/l

0.01

642

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

150

1.07

0.04

1.3

1.1

—

(3003129) Base excess in Capillary blood by calculation

1.10

0.04

1.0

1.5

-0.79

0.27

mmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

503

0.97

0.04

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

131

1.07

0.03

2.5

2.7

50721.43

40370.56

ug/l

1.32

131

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

0.93

0.03

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

370

0.97

0.03

1.2

1.5

85.57

112.27

u/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

389

0.98

0.02

1.3

1.2

3.30

5.58

u/ml

1.14

175

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

264

2626

1.01

0.02

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

1.06

0.01

1.6

103.80

151.63

umol/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

233

1.03

0.01

1.1

1.2

—

4.70

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

754

7527

1.00

0.01

1.7

30484343.54

29194282.96

pmol/l

0.02

620

6128

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

144

1.04

0.00

1.1

1.2

5.95

6.21

mmol/l

0.43

133

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

286

0.98

0.00

1.1

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

260

1.00

0.00

2.5

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

365

1.01

0.00

3.5

3.0

36.61

38.33

mg/l

0.04

280

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

100

1004

1.00

0.00

1.6

—

(21491868) Cryoglobulin [Mass/volume] in Serum

104

0.96

0.00

1.2

—

0.06

—

(3003338) MCHC [Mass/volume]

2521

25202

1.00

0.00

39.7

18.3

329.85

332.52

g/l

38.96

2502

24959

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

125

1.04

0.00

1.8

1.7

389.85

682.71

e6/l

2.50

120

(3010503) CD19 cells [#/volume] in Blood

105

0.95

0.00

1.6

1.9

0.07

0.13

e9/l

—

100

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

363

0.99

0.00

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

160

1.00

0.00

1.1

1.4

1.54

1.55

g/l

0.03

160

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

0.99

0.00

1.0

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.88

-0.00

1.2

17.87

15.72

umol/l

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

250.89

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

0.99

-0.00

1.0

1.1

—

30.00

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

3.8

—

20.67

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

9.24

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.92

-0.00

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.33

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.4

—

0.21

—

(3035933) Granulocytes/100 leukocytes in Blood

0.98

-0.00

1.4

1.5

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.13

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1273.33

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

4.8

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

3.78

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

1.92

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.89

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM – Malignant neoplasm of rectum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of rectum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of rectum (C3_RECTUM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints